![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Wenzhou Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Ribavirin, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2013-034 - Rev 00
This Chemical Type CEP, issued on June 12, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2109 associated with this CEP further emphasizes